Veri Medtech (VRHI) Reaches 1.3 million Patient Registrations
Veri Medtech Holdings (VRHI) has announced reaching a significant milestone of 1.3 million patient registrations on its proprietary healthcare technology platform. The company reports thousands of new patient registrations monthly and positions itself as an emerging alternative in the telemedicine market, estimated at $114 billion.
CEO Sam Adetunji states that 2025 will be a transformative year as the company aims to strategically position itself among current telemedicine providers, focusing on health and wellness prescription and non-prescription products and services.
Veri Medtech Holdings (VRHI) ha annunciato di aver raggiunto un traguardo significativo di 1,3 milioni di registrazioni di pazienti sulla sua piattaforma tecnologica sanitaria proprietaria. L'azienda riporta migliaia di nuove registrazioni di pazienti ogni mese e si posiziona come un'alternativa emergente nel mercato della telemedicina, stimato in 114 miliardi di dollari.
Il CEO Sam Adetunji afferma che il 2025 sarà un anno trasformativo poiché l'azienda mira a posizionarsi strategicamente tra i fornitori attuali di telemedicina, concentrandosi su prodotti e servizi per la salute e il benessere, sia prescritti che non prescritti.
Veri Medtech Holdings (VRHI) ha anunciado que ha alcanzado un hito significativo de 1,3 millones de registros de pacientes en su plataforma tecnológica de salud propietaria. La empresa informa sobre miles de nuevos registros de pacientes mensualmente y se posiciona como una alternativa emergente en el mercado de la telemedicina, estimado en 114 mil millones de dólares.
El CEO Sam Adetunji afirma que 2025 será un año transformador, ya que la empresa busca posicionarse estratégicamente entre los proveedores actuales de telemedicina, enfocándose en productos y servicios de salud y bienestar, tanto prescritos como no prescritos.
Veri Medtech Holdings (VRHI)는 자사의 독점 헬스케어 기술 플랫폼에서 130만 명의 환자 등록이라는 중요한 이정표를 달성했다고 발표했습니다. 이 회사는 매달 수천 건의 새로운 환자 등록을 보고하며 원격 의료 시장에서 1,140억 달러로 추정되는 신흥 대안으로 자리매김하고 있습니다.
CEO 샘 아데툰지는 2025년이 변혁의 해가 될 것이라고 말하며, 회사가 현재의 원격 의료 제공자들 사이에서 전략적으로 자리잡고, 건강 및 웰빙을 위한 처방 및 비처방 제품과 서비스에 집중할 것이라고 밝혔습니다.
Veri Medtech Holdings (VRHI) a annoncé avoir atteint une étape importante de 1,3 million d'inscriptions de patients sur sa plateforme technologique de santé propriétaire. L'entreprise rapporte des milliers de nouvelles inscriptions de patients chaque mois et se positionne comme une alternative émergente sur le marché de la télémédecine, estimé à 114 milliards de dollars.
Le PDG Sam Adetunji déclare que 2025 sera une année transformative, car l'entreprise vise à se positionner stratégiquement parmi les fournisseurs actuels de télémédecine, en se concentrant sur les produits et services de santé et de bien-être, qu'ils soient prescrits ou non.
Veri Medtech Holdings (VRHI) hat bekannt gegeben, dass sie einen bedeutenden Meilenstein von 1,3 Millionen Patientenregistrierungen auf ihrer proprietären Gesundheits-Technologie-Plattform erreicht hat. Das Unternehmen berichtet monatlich von Tausenden neuer Patientenregistrierungen und positioniert sich als aufstrebende Alternative im Telemedizinmarkt, der auf 114 Milliarden Dollar geschätzt wird.
CEO Sam Adetunji erklärt, dass 2025 ein transformierendes Jahr sein wird, da das Unternehmen plant, sich strategisch unter den aktuellen Telemedizinanbietern zu positionieren und sich auf Gesundheits- und Wellnessprodukte sowie Dienstleistungen mit und ohne Rezept zu konzentrieren.
- Achieved 1.3 million patient registrations milestone
- Thousands of new patient registrations added monthly
- Operating in a large $114 billion telemedicine market
- None.
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings (OTC Markets: (“VRHI”) ("Veri Medtech") announced today that it has reached 1.3 million patient registrations.
“2025 will prove to be a transformative year, as we work to strategically position Veri Medtech (VRHI) to be an alternative to current telemedicine providers. With thousands of new patient registrations per month, via our proprietary healthcare technology platform, Veri Medtech (VRHI) is poised and positioned to continue to capture marketshare as a leading provider for health and wellness prescription and non-prescription products and services, in the estimated
About Veri Medtech (OTC Markets: VRHI): Veri Medtech is a leading provider of health and wellness services and products, via its proprietary healthcare technology platform. Veri Medtech is strategically positioned to explore untapped opportunities, including the acquisition of complementary healthcare companies. This strategic growth approach allows us to leverage our technological advantage, expanding our offerings to a broader audience. Our successful track record in completing similar acquisitions ensures the swift integration of new patient databases, providing us with an instant avenue for revenue growth and a wider pool of patients open to diverse healthcare opportunities. For more information, please visit: www.VeriMedTech.com.
About Global Telemedicine: The global telemedicine market size was valued at USD 114.98 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of
About Prescription Products and Services: Certain products and services available through Veri Medtech can be purchased only with a prescription from a qualified medical provider. To access these products, you must first consult with a medical provider through our proprietary technology platform. We make this process simple and convenient. Through Veri Medtech, you can access a network of medical providers who can evaluate your specific needs based on your health information, and if appropriate, prescribe treatment. For more information, please visit: www.VeriMedTech.com.
Forward Looking Statements: Cautionary Note Regarding Forward-Looking Statements: This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Veri Medtech (OTC: "VRHI") and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
FAQ
How many patient registrations has Veri Medtech (VRHI) reached in 2025?
What is the current market size for telemedicine where VRHI operates?
How many new patient registrations does VRHI receive monthly?
What services does Veri Medtech (VRHI) offer in the telemedicine space?
